Foghorn Therapeutics (FHTX) Other Gross PP&E Adjustments (2020 - 2025)
Foghorn Therapeutics has reported Other Gross PP&E Adjustments over the past 6 years, most recently at -$26.1 million for Q4 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$26.1 million for Q4 2025, down 1693.47% from a year ago — trailing twelve months through Dec 2025 was -$26.1 million (down 1693.47% YoY), and the annual figure for FY2025 was -$26.1 million, down 1693.47%.
- Other Gross PP&E Adjustments for Q4 2025 was -$26.1 million at Foghorn Therapeutics, down from $16.1 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for FHTX hit a ceiling of $22.0 million in Q1 2021 and a floor of -$26.1 million in Q4 2025.
- Median Other Gross PP&E Adjustments over the past 5 years was -$7.4 million (2023), compared with a mean of -$5.4 million.
- Peak annual rise in Other Gross PP&E Adjustments hit 1997.91% in 2025, while the deepest fall reached 1693.47% in 2025.
- Foghorn Therapeutics' Other Gross PP&E Adjustments stood at -$17.0 million in 2021, then rose by 22.15% to -$13.3 million in 2022, then rose by 24.35% to -$10.0 million in 2023, then skyrocketed by 85.5% to -$1.5 million in 2024, then tumbled by 1693.47% to -$26.1 million in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$26.1 million (Q4 2025), $16.1 million (Q3 2025), and $15.4 million (Q2 2025) per Business Quant data.